Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Wanbangde Pharmaceutical Group Co., Ltd. Announces Environmental Measures for New Technical Upgrade Project: Annual Production Capacity of 5 tons of Resorcinol API and 500 tons of Cimetidine API

Date:

11 Jun,2022


The company plans to build a technical upgrade project aimed at producing 5 tons of resorcinol API and 500 tons of cimetidine API annually. The construction details of this project are now being publicly announced.

Previous page

Adhering to the Work Safety Law and Taking on Primary Responsibility | Wanbangde Pharmaceutical Group Holds 2022 "Work Safety Month" Kickoff Meeting

Spring Outing Diary | Wanbangde Pharmaceutical Group’s National Fitness Event Successfully Concludes

Next page

Related Recommendations

Image Name

2024/06/27

"Everyone Talks Safety, Everyone Knows How to Respond—Keeping Life Paths Clear" | Wanbangde Pharmaceutical Group Holds 2024 "Safety Production Month" Kickoff Meeting

Image Name

2024/06/03

[Literature Review] Huperzine A Improves Neurological Deficits After Spontaneous Subarachnoid Hemorrhage by Inhibiting Endothelial Cell Pyroptosis

Image Name

2024/06/03

Tech Month | Step into Wanbangde Pharmaceutical, get up close with scientific research, and embark together on a journey of pharmaceutical exploration.

< 1...101112...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38